Literature DB >> 17322250

Doubts over head injury studies.

Ian Roberts1, Richard Smith, Stephen Evans.   

Abstract

Mesh:

Substances:

Year:  2007        PMID: 17322250      PMCID: PMC1804156          DOI: 10.1136/bmj.39118.480023.BE

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  7 in total

1.  Improving clinical outcomes from acute subdural hematomas with the emergency preoperative administration of high doses of mannitol: a randomized trial.

Authors:  J Cruz; G Minoja; K Okuchi
Journal:  Neurosurgery       Date:  2001-10       Impact factor: 4.654

2.  High-dose mannitol.

Authors:  Lawrence F Marshall
Journal:  J Neurosurg       Date:  2004-03       Impact factor: 5.115

3.  Scientific misconduct. Cleaning up the paper trail.

Authors:  Jennifer Couzin; Katherine Unger
Journal:  Science       Date:  2006-04-07       Impact factor: 47.728

Review 4.  Mannitol for acute traumatic brain injury.

Authors:  A Wakai; I Roberts; G Schierhout
Journal:  Cochrane Database Syst Rev       Date:  2005-10-19

5.  Aggravation of vasogenic cerebral edema by multiple-dose mannitol.

Authors:  A M Kaufmann; E R Cardoso
Journal:  J Neurosurg       Date:  1992-10       Impact factor: 5.115

6.  Major clinical and physiological benefits of early high doses of mannitol for intraparenchymal temporal lobe hemorrhages with abnormal pupillary widening: a randomized trial.

Authors:  Julio Cruz; Giulio Minoja; Kazuo Okuchi
Journal:  Neurosurgery       Date:  2002-09       Impact factor: 4.654

7.  Successful use of the new high-dose mannitol treatment in patients with Glasgow Coma Scale scores of 3 and bilateral abnormal pupillary widening: a randomized trial.

Authors:  Julio Cruz; Giulio Minoja; Kazuo Okuchi; Enrico Facco
Journal:  J Neurosurg       Date:  2004-03       Impact factor: 5.115

  7 in total
  13 in total

1.  Managing suspected research misconduct.

Authors:  Charles Young; Fiona Godlee
Journal:  BMJ       Date:  2007-02-24

Review 2.  Surgical research in the UK.

Authors:  Thomas Edward Woodcock
Journal:  Ann R Coll Surg Engl       Date:  2009-04       Impact factor: 1.891

3.  How to find a meta-analysis you can trust.

Authors:  R L Nelson
Journal:  Tech Coloproctol       Date:  2019-08-28       Impact factor: 3.781

Review 4.  A State-of-the-Science Overview of Randomized Controlled Trials Evaluating Acute Management of Moderate-to-Severe Traumatic Brain Injury.

Authors:  Peter Bragge; Anneliese Synnot; Andrew I Maas; David K Menon; D James Cooper; Jeffrey V Rosenfeld; Russell L Gruen
Journal:  J Neurotrauma       Date:  2016-03-18       Impact factor: 5.269

5.  Analysis of citations to biomedical articles affected by scientific misconduct.

Authors:  Anne Victoria Neale; Rhonda K Dailey; Judith Abrams
Journal:  Sci Eng Ethics       Date:  2009-07-14       Impact factor: 3.525

Review 6.  Clinical trials in traumatic brain injury: past experience and current developments.

Authors:  Andrew I R Maas; Bob Roozenbeek; Geoffrey T Manley
Journal:  Neurotherapeutics       Date:  2010-01       Impact factor: 7.620

7.  Evaluation of mannitol as an osmotherapeutic agent in traumatic brain injuries by measuring serum osmolality.

Authors:  R M Sharma; R Setlur; M N Swamy
Journal:  Med J Armed Forces India       Date:  2011-08-07

8.  Effects of Osmotic Therapy on Pupil Reactivity: Quantification Using Pupillometry in Critically Ill Neurologic Patients.

Authors:  C Ong; M Hutch; M Barra; A Kim; S Zafar; S Smirnakis
Journal:  Neurocrit Care       Date:  2019-04       Impact factor: 3.210

9.  Cochrane: the unfinished symphony of research synthesis.

Authors:  Ian Roberts; Katharine Ker
Journal:  Syst Rev       Date:  2016-07-14

Review 10.  Pharmacological targeting of secondary brain damage following ischemic or hemorrhagic stroke, traumatic brain injury, and bacterial meningitis - a systematic review and meta-analysis.

Authors:  Thomas Beez; Hans-Jakob Steiger; Nima Etminan
Journal:  BMC Neurol       Date:  2017-12-07       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.